Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
J Obstet Gynaecol Can ; 33(1): 36-37, 2011 Jan.
Article in French | MEDLINE | ID: mdl-21272434

ABSTRACT

Contexte : La place des prothèses non résorbables dans la chirurgie du prolapsus vaginal a pris beaucoup d'ampleur ces dernières années. Les complications tardives commencent à apparaître. Cas : Nous vous présentons le cas d'une érosion tardive dans le bas rectum. Pour autant que nous sachions, il s'agit de la première mention de cette complication tardive de la prothèse Prolift. Dans ce cas, il s'agit probablement d'une nécrose de décubitus attribuable à une prothèse trop longue. Conclusion : Les prothèses non résorbables sont certainement une option dans le traitement des prolapsus vaginaux; toutefois, les complications de ces implants devraient être connues et les patientes devraient être avisées des risques.


Subject(s)
Rectal Diseases/etiology , Surgical Mesh/adverse effects , Uterine Prolapse/surgery , Female , Humans , Prostheses and Implants/adverse effects , Rectal Diseases/pathology
2.
Infect Control Hosp Epidemiol ; 25(2): 133-7, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14994939

ABSTRACT

OBJECTIVES: To compare the prevalence of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) carriage among injection drug users (IDUs) treated in an injection heroin maintenance program with that among IDUs treated in an oral methadone program, and to determine predictors of S. aureus carriage. DESIGN: Survey. SETTING: Two opiate maintenance programs at a psychiatric university clinic. PARTICIPANTS: A volunteer sample consisting of 94 (74%) of 127 IDUs treated in an injection opiate maintenance program with at least twice daily injections of heroin, and 70 (56%) of 125 IDUs treated in an oral methadone program. RESULTS: Addicts treated in the intravenous heroin substitution program had a significantly lower overall rate of S. aureus carriage (37 of 94 [39.4%] vs 42 of 70 [60%]; P = .009) and a significantly lower rate of nasal carriage (21 of 94 [22.3%] vs 30 of 70 [42.9%]; P = .005) than did addicts treated in the oral methadone program. Being treated in the oral methadone program was the only independent predictor of S. aureus carriage (odds ratio, 2.27; 95% confidence interval, 1.19-4.31; P = .012). All S. aureus isolates were susceptible to oxacillin. CONCLUSIONS: The regular use of needles under aseptic conditions did not increase the rate of S. aureus carriage among IDUs. Further studies are necessary to investigate whether the lower rate of S. aureus carriage among IDUs treated with intravenous heroin leads to a lower incidence of S. aureus infections in these patients.


Subject(s)
Carrier State , Heroin/administration & dosage , Methadone/administration & dosage , Opioid-Related Disorders/microbiology , Staphylococcus aureus/isolation & purification , Substance Abuse, Intravenous/microbiology , Administration, Oral , Adult , Female , Humans , Injections, Intravenous , Male , Opioid-Related Disorders/drug therapy , Prevalence , Substance Abuse, Intravenous/drug therapy , Switzerland
SELECTION OF CITATIONS
SEARCH DETAIL
...